RECQL5 is overexpressed in these cells and appears to contribute to maintaining their genomic stability with depletion of RECQL5 leading to increased replication stress, double strand breaks, replication fork collapse and sensitization to hydroxyurea (24) which is commonly used to treat MPN. The gene discussed is RECQL5; the disease is myeloproliferative neoplasm.